✦ LIBER ✦

Increasing the mutation rate for jagged1 mutations in patients with Alagille syndrome

✍ Scribed by David L. Suskind; Karen F. Murray

Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 128 KB
Volume: 46
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.21860

No coin nor oath required. For personal study only.

✦ Synopsis

Alagille syndrome (AGS) is caused by heterozygous mutations in JAG1, and mutations have been previously reported in about 70% of patients who meet clinical diagnostic criteria. We studied a cohort of 247 clinically well-defined patients, and using an aggressive and sequential screening approach we identified JAG1 mutations in 94% of individuals. Mutations were found in 232 out of 247 patients studied and 83 of the mutations were novel. This increase in the mutation rate was accomplished by combining rigorous clinical phenotyping, with a combination of mutation detection techniques, including fluorescence in situ hybridization (FISH), genomic and cDNA sequencing, and quantitative PCR. This higher rate of mutation identification has implications for clinical practice, facilitating genetic counseling, prenatal diagnosis, and evaluation of living-related liver transplant donors. Our results suggest that more aggressive screening may similarly increase the rate of mutation detection in other dominant and recessive disorders.

📜 SIMILAR VOLUMES

Jagged1 (JAG1) mutations in Alagille syn

Jagged1 (JAG1) mutations in Alagille syndrome: increasing the mutation detection rate

✍ DM Warthen; EC Moore; BM Kamath; JJD Morrissette; P Sanchez; DA Piccoli; ID Kran 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 297 KB

Jagged1 mutations in Alagille syndrome

✍ Nancy B. Spinner; Raymond P. Colliton; Cécile Crosnier; Ian D. Krantz; Michelle 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 355 KB 👁 1 views

Mutation analysis of Jagged1 (JAG1) in A

Mutation analysis of Jagged1 (JAG1) in Alagille syndrome patients

✍ Raymond P. Colliton; Lynn Bason; Feng-Min Lu; David A. Piccoli; Ian D. Krantz; N 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 21 KB 👁 2 views

Alagille syndrome (AGS) is an autosomal dominant disorder caused by mutations in Jagged1 (JAG1), a ligand in the evolutionarily conserved Notch signaling pathway. Previous studies have demonstrated that a wide spectrum of JAG1 mutations result in AGS. These include total gene deletions, protein trun

Jagged-1 mutation analysis in Italian Al

Jagged-1 mutation analysis in Italian Alagille syndrome patients

✍ Giuseppe Pilia; Manuela Uda; Dolores Macis; Fulvia Frau; Laura Crisponi; Fiorell 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 389 KB 👁 2 views

## Communicated by Riccardo Fodde Alagille syndrome (AGS) is an autosomal dominant disorder with developmental abnormalities affecting the liver, heart, eyes, vertebrae, and craniofacial region. The Jagged-1 (JAG1) gene, which encodes a ligand of Notch, has recently been found mutated in AGS. In th

Identification of 36 novel Jagged1 (JAG1

Identification of 36 novel Jagged1 (JAG1) mutations in patients with Alagille syndrome

✍ Albrecht Röpke; Annegret Kujat; Mechthild Gräber; Joannis Giannakudis; Ingo Hans 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 37 KB

Alagille syndrome (AGS) is an autosomal dominant disorder characterized by five major symptoms: cholestasis, vertebral deformity, heart malformations, ocular defects and peculiar facial appearance. The previously described Jagged1 (JAG1) gene on chromosome 20p12 has been identified as being responsi

Fifteen novel mutations in the JAGGED1 g

Fifteen novel mutations in the JAGGED1 gene of patients with Alagille syndrome

✍ Cécile Crosnier; Catherine Driancourt; Nicole Raynaud; Michelle Hadchouel; Michè 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 23 KB 👁 2 views

Mutations in the human JAGGED1 gene cause Alagille syndrome, an autosomal dominant developmental disorder. The gene encodes a transmembrane protein which is a ligand of Notch receptors. We report 23 mutations in previously undescribed probands, including 15 novel mutations and 8 recurrent mutations.